Cardioprotective Actions of Hydrogen Sulfide
Cardioprotective Actions of Hydrogen Sulfide
批准号:
8921357
负责人:
DAVID JOSEPH LEFER
金额:
$28.46万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hydrogen sulfide (H2S) has recently been identified as a physiologically important endogenous gaseous signaling molecule with a diverse array of biological activities. H2S is produced in micromolar quantities by two endogenous enzymes, cystathionine 3lyase (CGL) and cystathionine 2 synthase (CBS) and is critical for the maintenance of cardiovascular homeostasis. H2S attenuates leukocyte adhesion, modulates mitochondrial respiration, and inhibits both apoptosis, and oxidative stress. These physiological actions are ideal for the treatment of myocardial ischemia-reperfusion (MI-R) injury. Preliminary data clearly demonstrate that physiological levels of H2S significantly ameliorate MI-R injury and preserve left ventricular function. Preliminary data also indicate that H2S therapy triggers both "early" and "late" myocardial preconditioning. We also demonstrate that mice with cardiac-restricted CGL overexpression exhibit significantly increased myocardial H2S bioavailability and protection against myocardial I-R injury. The central hypothesis for the proposed studies is that H2S triggers a cardioprotective signaling cascade that confers robust cardioprotection in the setting of MI-R injury. The proposed studies will evaluate the various cardioprotective signals induced by H2S therapy during both "acute" and "chronic" pharmacological preconditioning as well as the during acute H2S therapy at the time of reperfusion. Specific Aim 1: To investigate the contribution of ATP sensitive K+ channels (KATP channels) in H2S- mediated cardioprotection against myocardial ischemia-reperfusion injury. In vitro studies will evaluate the effects of H2S on KATP channel activation and mitochondrial function. In vivo Studies will be performed using gene-targeted mice with cardiac myocyte deletion of KATP (Sur 1, Kir 6.1, and Kir 6.2 subunits) treated with H2S and subjected to MI-R. Specific Aim 2: To investigate the role of antioxidants in H2S-mediated cardioprotection. Studies will evaluate the acute and chronic effects of H2S on Nrf-2 activation and oxidative stress during MI-R. Studies will also investigate the effects of H2S on the induction of antioxidant signaling pathways in the myocardium prior to MI-R. Specific Aim 3: To investigate the role of the RISK pathway in H2S-mediated cardioprotection. Studies will investigate the effects of H2S on RISK pathway (PI3K, Akt, PKC5, and Erk 1/2) activation, downstream anti-apoptotic signaling, MPTP opening, and myocardial cell death following MI-R. The proposed studies will significantly extend our current understanding of the molecular and cellular pathophysiology of MI-R injury and provide the foundation for the development of H2S therapy for the treatment of acute myocardial infarction.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/circulationaha.116.027039
发表时间:
2017-07-04
期刊:
Circulation
影响因子:
37.8
作者:
[Lefer DJ, Marbán E]
通讯作者:
Marbán E
DOI:
10.1586/ecp.10.56
发表时间:
2011-01
期刊:
Expert review of clinical pharmacology
影响因子:
4.4
作者:
[Predmore BL, Lefer DJ]
通讯作者:
Lefer DJ
DOI:
10.1161/jaha.117.008268
发表时间:
2018-03-03
期刊:
Journal of the American Heart Association
影响因子:
5.4
作者:
[Trivedi RK, Polhemus DJ, Li Z, Yoo D, Koiwaya H, Scarborough A, Goodchild TT, Lefer DJ]
通讯作者:
Lefer DJ
DOI:
10.1016/j.yjmcc.2013.08.002
发表时间:
2013-11
期刊:
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
影响因子:
5
作者:
[Nicholson, Chad K., Lambert, Jonathan P., Chow, Chi-Wing, Lefer, David J., Calvert, John W.]
通讯作者:
Calvert, John W.
DOI:
10.1155/2014/768607
发表时间:
2014
期刊:
Scientifica
影响因子:
3.2
作者:
[Polhemus DJ, Calvert JW, Butler J, Lefer DJ]
通讯作者:
Lefer DJ
共 12 条
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10391506
-
项目类别:
-
资助金额:$56.2万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10162413
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Hydrogen Sulfide Regulation in Cardioprotection
-
批准号:10610727
-
项目类别:
-
资助金额:$54.7万
-
财政年份:2020
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
-
批准号:10077584
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2019
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Mitochondrial DNA Repair Enzyme for Heart Failure
-
批准号:9408031
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2017
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel antifibrotic small molecules for the treatment of heart failure
-
批准号:9142025
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2016
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Sulfide Releasing Agents for Ischemic Injury
-
批准号:8629076
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2014
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Novel Sulfide Releasing Agents for Ischemic Injury
-
批准号:8889814
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2014
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8289582
-
项目类别:
-
资助金额:$25.42万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:7900081
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8835549
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8399050
-
项目类别:
-
资助金额:$8.06万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:7754425
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:8085943
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8207216
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Nitrite Mediated Cardioprotection
-
批准号:7742542
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:7599368
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Cardioprotective Actions of Hydrogen Sulfide
-
批准号:8011098
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES
-
批准号:6184820
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1999
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
Mechanism of Myocardial Reperfusion Injury in Diabetes
-
批准号:6998480
-
项目类别:
-
资助金额:$24.23万
-
财政年份:1999
-
负责人:DAVID JOSEPH LEFER
-
依托单位:
海外基金